Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma–COPD Overlap in vivo and in vitro
Shuyi Li, Yang Hui, Jiqiao Yuan, Ziqian Zhang, Xuyu Li, Nan Fang, Mingbao Lin, Qi Hou Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People’s Republic of ChinaCorrespondence: Mingbao Lin; Qi Hou Tel +86-10-63165192; +86-10-...
Enregistré dans:
Auteurs principaux: | Li S, Hui Y, Yuan J, Zhang Z, Li X, Fang N, Lin M, Hou Q |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/71c6ae6456f94e4d83394065b28f9221 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Racial Differences in Prevalence and Clinical Characteristics of Asthma–Chronic Obstructive Pulmonary Disease Overlap
par: Yong Suk Jo, et autres
Publié: (2021) -
Small Airways Response to Bronchodilators in Adults with Asthma or COPD: A Systematic Review
par: Almeshari MA, et autres
Publié: (2021) -
Multiple Components Rapidly Screened from Perilla Leaves Attenuate Asthma Airway Inflammation by Synergistic Targeting on Syk
par: Yang H, et autres
Publié: (2020) -
Effectiveness of Telemonitoring for Respiratory and Systemic Symptoms of Asthma and COPD: A Narrative Review
par: Esther Metting, et autres
Publié: (2021) -
Serum CYR61 Is Associated With Airway Inflammation and Is a Potential Biomarker for Severity in Chronic Obstructive Pulmonary Disease
par: Zhu-Xia Tan, et autres
Publié: (2021)